Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research

Tuberculosis (TB) remains a serious global health threat and an improved vaccine is urgently needed. New candidate TB vaccines are tested using preclinical animal models such as mice, guinea pigs, cattle and non-human primates. Animals are routinely infected with virulent Mycobacterium tuberculos...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Tanner, R, McShane, H
स्वरूप:	Journal article
प्रकाशित:	ALTEX Edition 2016

समान संसाधन

Vaccines for tuberculosis
द्वारा: McShane, H
प्रकाशित: (2013)

Reducing, refining and replacing the use of animals in toxicity testing /
द्वारा: Allen, David G. (David Glenwood), और अन्य
प्रकाशित: (2014)

Vaccine strategies against tuberculosis
द्वारा: H McShane
प्रकाशित: (2009-03-01)

Insights and challenges in tuberculosis vaccine development
द्वारा: McShane, H
प्रकाशित: (2019)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
द्वारा: McShane, H
प्रकाशित: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
द्वारा: McShane, H
प्रकाशित: (2011)

Tuberculosis vaccines: Progress and challenges
द्वारा: Checkley, A, और अन्य
प्रकाशित: (2011)

Improving tuberculosis vaccine trial efficiency: a tough nut to crack
द्वारा: McShane, H
प्रकाशित: (2023)

Why don’t we have an effective tuberculosis vaccine yet?
द्वारा: Davenne, T, और अन्य
प्रकाशित: (2016)

Editorial: 3Rs approach (replace, reduce and refine animal models) to improve preclinical research
द्वारा: Laura Calvillo
प्रकाशित: (2022-10-01)

Clinical testing of tuberculosis vaccine candidates
द्वारा: Hatherill, M, और अन्य
प्रकाशित: (2016)

The VALIDATE network: accelerating vaccine development for tuberculosis, leishmaniasis, melioidosis and leprosy
द्वारा: Vermaak, S, और अन्य
प्रकाशित: (2023)

A Novel Dental Caries Model Replacing, Refining, and Reducing Animal Sacrifice
द्वारा: Amit Wolfoviz-Zilberman, और अन्य
प्रकाशित: (2021-08-01)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
द्वारा: Hopkins, R, और अन्य
प्रकाशित: (2011)

Tuberculosis vaccines in the era of Covid-19 - what is taking us so long?
द्वारा: Dockrell, HM, और अन्य
प्रकाशित: (2022)

Factors influencing the higher incidence of tuberculosis among migrants and ethnic minorities in the UK
द्वारा: Hayward, S, और अन्य
प्रकाशित: (2018)

Human and Bovine Tuberculosis
द्वारा: McShane, H
प्रकाशित: (2016)

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges
द्वारा: Stylianou, E, और अन्य
प्रकाशित: (2019)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
द्वारा: McShane, H, और अन्य
प्रकाशित: (2014)

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
द्वारा: McShane, H, और अन्य
प्रकाशित: (2014)

Vaccination against tuberculosis: how can we better BCG?
द्वारा: Pitt, J, और अन्य
प्रकाशित: (2013)

Vaccination against tuberculosis: How can we better BCG?
द्वारा: Pitt, J, और अन्य
प्रकाशित: (2013)

Tuberculosis vaccines in the era of Covid-19 – what is taking us so long?
द्वारा: Hazel M. Dockrell, और अन्य
प्रकाशित: (2022-05-01)

The humoral immune response to BCG vaccination
द्वारा: Tanner, R, और अन्य
प्रकाशित: (2019)

Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review
द्वारा: Mcshane, H, और अन्य
प्रकाशित: (2016)

Survey of Canadian animal-based researchers' views on the Three Rs: replacement, reduction and refinement.
द्वारा: Nicole Fenwick, और अन्य
प्रकाशित: (2011-01-01)

Vaccine strategies against tuberculosis.
द्वारा: Mcshane, H
प्रकाशित: (2009)

Tuberculosis vaccines in clinical trials.
द्वारा: Rowland, R, और अन्य
प्रकाशित: (2011)

The Sharing Experimental Animal Resources, Coordinating Holdings (SEARCH) Framework: Encouraging Reduction, Replacement, and Refinement in Animal Research.
द्वारा: Bethny Morrissey, और अन्य
प्रकाशित: (2017-01-01)

Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
द्वारा: Richard Hopkins, और अन्य
प्रकाशित: (2011-01-01)

Controlled human infection models: is it really feasible to give people tuberculosis?
द्वारा: McShane, H
प्रकाशित: (2020)

Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in Gambian infants.
द्वारा: Ota, M, और अन्य
प्रकाशित: (2011)

Developing an improved vaccine against tuberculosis.
द्वारा: Mcshane, H
प्रकाशित: (2004)

Local pulmonary immunological biomarkers in tuberculosis
द्वारा: Morrison, H, और अन्य
प्रकाशित: (2021)

Refining animal research: The Animal Study Registry.
द्वारा: Bettina Bert, और अन्य
प्रकाशित: (2019-10-01)

Tuberculosis vaccines: progress and challenges.
द्वारा: Checkley, A, और अन्य
प्रकाशित: (2011)

Tuberculosis vaccines: present and future.
द्वारा: Minassian, A, और अन्य
प्रकाशित: (2008)

Challenges in developing a controlled human tuberculosis challenge model
द्वारा: Jackson, S, और अन्य
प्रकाशित: (2022)

In vitro mycobacterial growth inhibition assays: A tool for the assessment of protective immunity and evaluation of tuberculosis vaccine efficacy
द्वारा: Mcshane, H, और अन्य
प्रकाशित: (2017)

Refinement of Animal Experiments: Replacing Traumatic Methods of Laboratory Animal Marking with Non-Invasive Alternatives
द्वारा: Ilya Klabukov, और अन्य
प्रकाशित: (2023-11-01)